TITLE

Obesity Treatment and Trends, Today and Tomorrow

AUTHOR(S)

Harris, Michael

PUB. DATE

May 2010

SOURCE

BioWorld International;5/26/2010, Vol. 15 Issue 21, Special section p1

SOURCE TYPE

Periodical

DOC. TYPE

Article

ABSTRACT

The article discusses various issues concerning obesity. It reveals that obesity is globally increasing but the drug and medical technology markets has become reliant on developed products for major illnesses. Surgery, according to the author, is the treatment of choice for obesity. They highlight the problems associated with the inefficacy/side effect of drugs for obesity. In addition, the article cites that there are 38 drugs under clinical trials for obesity treatment.

ACCESSION #

50993769

 

Related Articles

• NUTRITION.  // Monthly Prescribing Reference;Jul2011, Vol. 27 Issue 7, p248 

  A chapter of the book "Monthly Prescribing Reference" is presented. It presents the drugs used for treating different types of nutrition disorders, including PamLab LLC's Cerofolin for treating hyperhomocysteinemia, Biocodex SA's Florastor to promote intestinal health and maintain normal bowel...

• DRUGS FOR OBESITY. Mead, Mike // Practice Nurse;9/10/2004, Vol. 28 Issue 4, p64 

  Focuses on prescription drugs available to help obese patients to lose weight. Clinical indications of Sibutramine and Orlistat; Contraindications and side effects of the drugs; Importance of monitoring patients who are taking drug therapy.

• SECTION 7 METABOLIC DISORDERS.  // MPR - Pharmacist's Edition;Fall2014, Vol. 8 Issue 3, p131 

  The article offers information on several drugs for the treatment of obesity. The Belviq weight-loss medication from pharmaceutical firm Eisai Co. Ltd. should be used together with a reduced-calorie diet and weight maintenance to treat obesity. Obese patients are advised to take the Qsymia...

• The Current Status and Future Perspectives of Studies of Cannabinoid Receptor 1 Antagonists as Anti-Obesity Agents. Hyeon-Kyu Lee; Eun Bok Choi; Chwang Siek Pak // Current Topics in Medicinal Chemistry;Apr2009, Vol. 9 Issue 6, p482 

  Since the discovery of rimonabant (Acomplia: 1), a large effort has been directed at the discovery of new, potent and selective CB1R antagonists that serve as anti obesity drugs. As a result, a number of compounds reached various stages of clinical trials by late 2008. However, the announcement...

• The Global Epidemic of Obesity: Why Global Approaches Won't Work. Miller, Wayne C. // Healthy Weight Journal;Nov/Dec2001, Vol. 15 Issue 6, p81 

  Editorial. Explores the global epidemic of obesity. Efforts to prevent overweight and obesity; Assumptions underlying obesity treatment paradigms; Efficiency of obesity treatment programs.

• Management of Obesity in Adults. Brunton, Stephen A. // Journal of Family Practice;Jul2014 Supplement, Vol. 63, pS1 

  An introduction is presented in which the author discusses various articles within the issue on topics including on the epidemiology and pathophysiology of obesity in adults, the significance of good communications with obese and overweight patients, and obesity management.

• NIH Clinical Guidelines on Obesity: A Summary.  // Healthy Weight Journal;Mar/Apr1999, Vol. 13 Issue 2, p20 

  Focuses on guidelines issued by the United States National Institutes of Health on obesity treatment. Information on obesity; Prevalence of obesity in the country; Persons at risk of being overweight; Therapeutic approaches to obesity; Goals for weight loss and management.

• Drug ban threatens obesity control.  // USA Today Magazine;Dec97, Vol. 126 Issue 2631, p7 

  Reports that controversy over weight-reduction drugs could threaten future efforts to develop and prescribe medications for obesity. The withdrawl of two obesity drugs fenfluramine and dexfenfluramine from the market in 1997; Reasons they were removed from the market; Number of people who die...

• Poster 227: Disability in Obesity. Capodaglio, Paolo; Brunani, Amelia; Donini, Lorenzo M.; Spera, Giovanni // PM & R: Journal of Injury, Function & Rehabilitation;Sep2010 Supplement 9S, Vol. 2, pS102 

  No abstract available.

Read the Article